Development of a novel class of interleukin-2 immunotherapies for metastatic cancer. Swiss Medical Weekly, [S. l.], v. 149, n. 0304, p. w14697, 2019. DOI: 10.4414/smw.2019.14697. Disponível em: https://www.smw.ch/index.php/smw/article/view/2564. Acesso em: 13 oct. 2025.